Skip to content
Open access

Retroperitoneal Manifestations of Type 1 Neurofibromatosis: A Case Report

Aug 2026 · Scholars Journal of Medical Case Reports · Vol 14, pp. 1930-1932 · 0 citations

Abstract

Type 1 neurofibromatosis (NF1) is a common autosomal dominant genetic disorder characterized by various manifestations, including plexiform neurofibromas; retroperitoneal involvement is rare but can complicate diagnosis and management. We report the case of a 42-year-old man presenting with pelvic pain and a left gluteal mass. Clinical examination revealed café-au-lait macules, cutaneous nodules, and Lisch nodules, and imaging showed nodular formations surrounding the bladder and rectum; a biopsy confirmed the presence of benign plexiform neurofibromas. Retroperitoneal neurofibromas in NF1 have an incidence of 1 to 3% and are often asymptomatic, although their growth may lead to local compression and clinical symptoms; identification through imaging and histological confirmation are essential for guiding management, which is often limited to monitoring and symptomatic treatment. NF1 is a disease with diverse manifestations requiring regular follow-up, and although rare, retroperitoneal neurofibromas play a diagnostic role and necessitate appropriate management.

Read PDF

Similar papers

Open access Sep 2026

A Rare Case of Early-Onset Periampullary Adenocarcinoma in a Neurofibromatosis Type 1 Patient

Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder primarily associated with neurocutaneous manifestations. Gastrointestinal involvement, though less recognized, can include both benign and malignant neoplasms. We describe a rare case of a 26-year-old woman with NF1 presenting with progressive obstr...

Abm Shakil Gani, Mahbuba Tabashsum, Sabbir Hossain et al. · 0 citations
Case report Open access Oct 2026

Delayed diagnosis of neurofibromatosis type I with an index presentation of haemothorax

Abstract Neurofibromatosis type I (NF1) is an autosomal dominant condition that typically presents with cutaneous features, including neurofibromas and Lisch nodules. At the time of writing, vasculopathies are not part of the updated diagnostic criteria. We present the case of a 36-year-old woman with sudden-onset ches...

Isaac Roberts, Theodore Hughes, Malcolm Will · 0 citations
Open access Aug 2026

A 14 Year Diagnostic Delay of Neurofibromatosis Type 1 in a Patient with Hypertension and Leukemia: A Case Report

A 27 year old woman with severe hypertension, acute myeloid leukemia, and chronic graft versus host disease was admitted for acute pyelonephritis, leading to a clinical diagnosis of NF1 based on NIH criteria, highlighting that NF1 can remain undiagnosed for years in patients with complex medical histories.

Ghalia Khellaf, H. Sahel, A. Benziane · 0 citations
Open access Aug 2026

Clinical Management and Therapeutic Advances in Pediatric Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

While surgical boundaries remain highly restricted in deep-tissue infiltrative PN, the introduction of targeted MEK inhibitors marks a pivotal therapeutic paradigm shift and improving timely access to these therapies may help prevent further functional deterioration in selected pediatric patients.

Karina Quintero, Lorelay Cárcamo, Andrés Bernales et al. · 0 citations
Open access Sep 2026

Renal and Intracranial Vasculopathy in an Adolescent with Neurofibromatosis Type 1: A Case Report

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant multisystem disorder characterized by variable clinical expression. Although cutaneous manifestations are the most recognizable features, NF1 may be associated with clinically significant vascular abnormalities involving multiple arterial territories....

Emily Patron Chi, Veronica Leon Burgos · 0 citations
Open access Sep 2026

Neurofibromatosis Type 1 Tumor Involving the Anterosuperior Mediastinum With a Rare c.147C>G Germline Mutation: A Case Report

This case underscores the importance of a comprehensive, multidisciplinary approach in the evaluation of mediastinal masses to achieve an accurate diagnosis and highlights the role of genetic testing in facilitating risk stratification and informing preventive strategies aimed at reducing the risk of progression from N...

Yu Qi, Sheng-Hai Wang, Zhao-Kun Sun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.